Clinical Trial Update: Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing inhaled insulin (Exubera) with subcutaneous human insulin in adults with Type 2 diabetes was terminated, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Exubera (insulin inhalation) (insulin inhalation)
• insulin human (insulin human)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus | Phase 3 | Status: TERMINATED | Results posted: 2010-01-18